Ablatherm® HIFU thermal ablation treatment

High-intensity focused ultrasound (HIFU) technology

Ablatherm® HIFU treatment (or thermal ablation) treats prostate cancer by focusing high-intensity ultrasound waves on the affected area, causing localized heating that destroys the cells in the gland without damaging the surrounding tissue.

Focused ultrasound works in the same way as rays of sunlight that pass through a magnifying glass and are concentrated at a single point, causing a significant temperature rise around the focal point.
Thermal ablation is a non-invasive (incisionless and radiation-free) treatment that has been used in humans since 1993.

With more than 22,000 treatments performed using Ablatherm® HIFU, it is no longer considered as an experimental procedure and its effectiveness has been demonstrated.

The Ablatherm® HIFU is recognized by the orders of urology specialists in several countries.

Ablatherm® HIFU device

 

 

Last update 1 June 2010. 

This site complies with the HONcode standard for trustworthy health information.
Verify here.